15 hedge funds and large institutions have $1.14M invested in BiomX in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.

Holders
15
Holders Change
+4
Holders Change %
+36.36%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
3
Closed
Calls
$6K
Puts
Net Calls
+$6K
Net Calls Change
+$1K
Name Market Value Shares Shares
Change
Shares
Change %
JJ
1
Johnson & Johnson
New Jersey
$725K 2,133,402
MI
2
MMCAP International
Cayman Islands
$233K 684,451
RA
3
Royce & Associates
New York
$54K 158,655 -170,000 -52%
Millennium Management
4
Millennium Management
New York
$30K 87,757 +8,824 +11%
VF
5
Virtu Financial
New York
$23K 68,813 +68,813 New
BCM
6
Bridgeway Capital Management
Texas
$20K 58,700
Jane Street
7
Jane Street
New York
$20K 59,768 +37,306 +166%
Citadel Advisors
8
Citadel Advisors
Florida
$11K 31,945 +31,945 New
Renaissance Technologies
9
Renaissance Technologies
New York
$10K 30,300 -11,900 -28%
Walleye Capital
10
Walleye Capital
New York
$5K 13,556 +13,556 New
Walleye Trading
11
Walleye Trading
New York
$4K 10,422 +10,422 New
BlackRock
12
BlackRock
New York
$2K 5,750
UBS Group
13
UBS Group
Switzerland
$1K 3,741 -6,867 -65%
O
14
OrbiMed
New York
$957 2,813,489
CFGS
15
Concourse Financial Group Securities
Alabama
Bank of America
16
Bank of America
North Carolina
$0 2
JGC
17
J. Goldman & Co
New York